New Solutions for Diabetes and Obesity
Microbiome Restoration and Modulation
Realize Therapeutics is focused on providing Health Care Practitioners (HCPs) with medical nutrition solutions for their patients suffering from obesity and type 2 diabetes. Realize’s strategy is to develop microbe and endocannabinoid formulations to restore and modulate the human microbiome. We intend to validate our formulations through human clinical trials and commercialize them as branded SmartBiome™ products, exclusively through HCPs in the US and through partners globally.
Realize Therapeutics’ approach is based upon recognition that modern medical conditions stem from microbiome disruptions. We provide healthcare practitioners needed tools in the fight against chronic health issues.
a great team
OUR INSPIRATION, WILLIAM DAVIS, M.D.
Co-Founder and CMO, is a cardiologist and world-renown expert in gut and heart health, and New York Times best-selling author of 10 books (including the Wheat Belly series with nearly 4 million copies sold).
notify me of new developments
Keep up to date with new developments from Realize Therapeutics